目的探讨冠心病患者室性心律失常的有效治疗方法。
Objective To investigate an effectively therapeutic method for ischemic ventricular arrhythmias.
对于有室性心动过速及不服用抗心律失常药物的植入心律转复除颤器患者也需特别注意。
The same may also be true for patients with implantable cardioverter defibrillators who have a history of ventricular tachycardia and who are not taking antiarrhythmic medications.
目的植入型心律转复除颤器(ICD)是恶性室性心律失常患者惟一有效的治疗措施。
Objective Implantable cardioverter defibrillator (ICD) is the only effective therapy in patients with life-threatening ventricular arrhythmias.
结论：心力衰竭合并室性心律失常在积极治疗心力衰竭的同时应用胺碘酮进行治疗，可有效地控制患者的病情，且安全、有效。
Conclusion: heart failure with ventricular arrhythmia treatment of heart failure while in the active Amiodarone treatment, which can effectively control the patient's condition, safe and effective.
【译】2型糖尿病和心血管疾病患者中，低血糖的发生与室性心律失常的关系。
Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases.
方法：测定56例急性心肌梗死患者心电图QT间期离散度与校正的QT间期离散度，将其分为室性心律失常组和无室性心律失常组，并进行比较。
Methods:QTd and corrected QT dispersion(QTcd)were measured on electrocardiogram in 56 patients with AMI. QTd and QTcd in the group of patients with VT were compared with that of patients without VT.
结果在6个月的随访中，所有患者未观察到与起搏器相关的房性和室性心律失常及其他不良反应事件。
Results Patients were followed up for 6 months, and no pacemaker-associated atrial and ventricular arrhythmias and other adverse events were observed.
结果28例患者发生并发症，主要为呼吸道并发症、室性心律失常、低心排、出血及肾功能衰竭等。
Results 8 patients died after operation, the reasons of death were failure of kidney function, ventricular arrhythmia, cerebral thrombus and infection. 28 Complications occurred in the group.
结果28例患者发生并发症，主要为呼吸道并发症、室性心律失常、低心排、出血及肾功能衰竭等。
Results 8 patients died after operation, the reasons of death were failure of kidney function, ventricular arrhythmia, cerebral thrombus and infection. 28 Complications occurred in the group.
应用推荐